Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yu Fan

Q4 2024 · 13F-HR

Yu Fanholdings as filed

Filed 2025-02-14 · accession 0000950123-25-002400

$53.2M
Reported value
7
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
15678C102CBLLCERIBELL INC$31.6M59.4%1,222,202CommonSOLE
14179K101CRGXCARGO THERAPEUTICS INC$13.2M24.7%912,000CommonSOLE
022307102ALMSALUMIS INC$6.2M11.7%789,618CommonSOLE
156944100CGONCG ONCOLOGY INC$1.3M2.41%163,456CommonSOLE
14843C105CSTLCASTLE BIOSCIENCES INC$599,7051.13%22,503CommonSOLE
786700104SGMTSAGIMET BIOSCIENCES INC$257,3550.48%57,190CommonSOLE
747324101PYXSPYXIS ONCOLOGY INC$108,1130.20%69,303CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.